News

Published on 12 Jan 2022 on Insider Monkey via Yahoo Finance

Is Kymera Therapeutics, Inc. (KYMR) A Good Stock To Buy?


Article preview image

We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, smart money investors have to conduct complex analyses, spend many resources and use tools that are not always available for the general crowd. This doesn't mean that they don't have occasional colossal losses; they do (like Melvin Capital's recent GameStop losses). However, it is still a good idea to keep an eye on hedge fund activity. With this in mind, as the current round of 13F filings has just ended, let’s examine the smart money sentiment towards Kymera Therapeutics, Inc. (NASDAQ:KYMR).

Is KYMR a good stock to buy? Hedge fund interest in Kymera Therapeutics, Inc. (NASDAQ:KYMR) shares was flat at the end of last quarter. This is usually a negative indicator. Our calculations also showed that KYMR isn't among the 30 most popular stocks among hedge funds (click for Q2 rankings). At the end of this article we will also compare KYMR to other stocks including Prospect Capital Corporation (NASDAQ:PSEC), Globalstar, Inc. (PINK:GSAT), and Alignment Healthcare, Inc. (NASDAQ:ALHC) to get a better sense of its popularity.

At Insider Monkey, we scour multiple sources to uncover the next great investment idea. For example, lithium prices have more than doubled over the past year, so we go through lists like the 10 best EV stocks to pick the next Tesla that will deliver a 10x return. Even though we recommend positions in only a tiny fraction of the companies we analyze, we check out as many stocks as we can. With all of this in mind we're going to take a gander at the fresh hedge fund action surrounding Kymera Therapeutics, Inc. (NASDAQ:KYMR).

NASDAQ.LILM price evolution
NASDAQ.ALXO price evolution
NASDAQ.KYMR price evolution
NYSE.GSAT price evolution
NASDAQ.RXT price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Insider Sell: CFO Bruce Jacobs Sells 3,934 Shares of Kymera Therapeutics Inc (KYMR)

Kymera Therapeutics Inc (NASDAQ:KYMR) CFO Bruce Jacobs has sold 3,934 shares of the company's sto...

GuruFocus.com via Yahoo Finance 4 Mar 2024

Earnings Update: Kymera Therapeutics, Inc. (NASDAQ:KYMR) Just Reported And Analysts Are Trimming...

Investors in Kymera Therapeutics, Inc. (NASDAQ:KYMR) had a good week, as its shares rose 8.3% to ...

Simply Wall St. via Yahoo Finance 24 Feb 2024

Kymera Therapeutics, Inc. (NASDAQ:KYMR) Q4 2023 Earnings Call Transcript

Kymera Therapeutics, Inc. (NASDAQ:KYMR) Q4 2023 Earnings Call Transcript February 22, 2024 Kymera...

Insider Monkey via Yahoo Finance 23 Feb 2024

Kymera Therapeutics Inc (KYMR) Reports Q4 and Full Year 2023 Financial Results

Collaboration Revenues: Increased to $47.9 million in Q4 and $78.6 million for the full year 2023...

GuruFocus.com via Yahoo Finance 22 Feb 2024

Director Jeffrey Albers Sells 5,000 Shares of Kymera Therapeutics Inc (KYMR)

On February 21, 2024, Director Jeffrey Albers sold 5,000 shares of Kymera Therapeutics Inc (NASDA...

GuruFocus.com via Yahoo Finance 21 Feb 2024

Kymera Therapeutics, Inc. (KYMR) Expected to Beat Earnings Estimates: Should You Buy?

Wall Street expects a year-over-year increase in earnings on higher revenues when Kymera Therapeu...

Zacks via Yahoo Finance 15 Feb 2024

Chief Medical Officer Jared Gollob Sells 46,137 Shares of Kymera Therapeutics Inc

Jared Gollob, Chief Medical Officer of Kymera Therapeutics Inc (NASDAQ:KYMR), sold 46,137 shares ...

GuruFocus.com via Yahoo Finance 10 Feb 2024

Kymera Therapeutics, Inc.'s (NASDAQ:KYMR) 34% Share Price Surge Not Quite Adding Up

The Kymera Therapeutics, Inc. (NASDAQ:KYMR) share price has done very well over the last month, p...

Simply Wall St. via Yahoo Finance 18 Dec 2023

BIOTECHNOLOGY VALUE FUND L P Adds to Its Stake in Kymera Therapeutics Inc

On November 3, 2023, BIOTECHNOLOGY VALUE FUND L P (Trades, Portfolio), a prominent investment fir...

GuruFocus.com via Yahoo Finance 7 Nov 2023

Kymera Therapeutics, Inc. (NASDAQ:KYMR) Q3 2023 Earnings Call Transcript

Kymera Therapeutics, Inc. (NASDAQ:KYMR) Q3 2023 Earnings Call Transcript November 4, 2023 Operato...

Insider Monkey via Yahoo Finance 5 Nov 2023